Stock engaged in the production of investment castings, vacuum castings and many more catering to industries like Defence, Aerospace, and many more jumps 5 percent in the day’s trade upon receiving long-term work order from Israel Weapons Industries.
Price Action
With a market capitalization of Rs. 448 Crores, the shares of Investment & Precision Castings Limited were trading at Rs. 895 per equity share, up 2.5 percent from its previous day’s close price of Rs. 874.05.
What Happened
Investment & Precision Castings Limited has announced that it has entered into a long-term contract with Israel Weapons Industries for the export of precision investment casting components for the defence sector and it is expected to generate consistent revenues over the next four years.
Management Message
“This strategic agreement highlights I&PCL’s growing presence in the global defense market and our capability to meet the stringent standards required for critical applications. This development is a testament to the Company’s advanced manufacturing capabilities, commitment to quality, and dedication to supporting the defense industry worldwide.
This accomplishment demonstrates our unwavering commitment to excellence, innovation, and the trust our stakeholders have placed in us. We are excited to explore new horizons and create even greater opportunities for growth and collaboration.”
About the Company
Investment & Precision Castings Limited is engaged in the production of investment castings. It also supplies fully machined, treated, and ready-for-use components for domestic automobile manufacturers and manufactures vacuum castings that find application across aerospace, defence, and medical implants.
It caters to industries like Automobile, Power Generation, Valves & Pumps, Electrical & Electronics, Dairy & Food Processing, Earthmoving Machinery, Air-conditioning & Refrigeration, Printing, Textile Machinery, Compressors, Cutting Tools, Machine Tools, Locomotives, Hand Tools, Sewing Machines, Atomic Energy, Defence, Aerospace & Space Shuttle, and Medical Implants.
Financials & Ratios
Its revenue from operations declined by 6.2 percent from Rs. 44.99 Crores in Q2FY24 to Rs. 42.2 Crores in Q2FY25, accompanied by profits of Rs. 2.53 Crores to Rs. 1.54 Crores.
In terms of Return ratios, it has reported a return on equity (ROE) of 6.52 percent, and a return on capital employed (ROCE) of 9.86 percent. It has reported a debt-to-equity ratio of 0.8.
Written by: Bharath K.S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
